Tweets
Swedish study found 1774 systemic sclerosis (SSc) pts in 2015 w/ median age 65 yrs (84% women) = prevalence=22.7 per 100,000 . Incidence (2004-2015) was 11.9 per 1,000,000 PYs - incidence remained stable; F were 5x more common than M. https://t.co/eqpBmbatSm https://t.co/nq4AFrTAfQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
10 yr Spanish study evaluated PET/CT in newly dx inflammatory myositis (except IBM); /77131 IIM pts had PET/CT screening for occult cancer with AUC ROC of 0.87; those not evaluated for OC did not develop cancer after median 3.3 years https://t.co/425o2cEhbJ https://t.co/5EWQzL07he
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
MTX-Sparing in myasthenia gravis. 18-mo OL RCT of MTX vs PBO in 35 recently Dx, pred Rx MG pts (MGFA Class II/III) showed @ 18 mos MTX reduced Pred use (5,663 vs 6,684 mg total), w/ shorter pred reduction times and less daily dose mos 6, 9–18 https://t.co/8t2sJMwBnx https://t.co/3G0wd1FQ2s
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
French study of "Pre-Hab" before Total Knee replacement (prospective, OL, randomized trial) in 262 Knee OA pts >50yrs; saw no benefit of PreHab before TKR. 4 d post surgery, functional independence was same in PreHab (34%) & control (27%) https://t.co/0kXMNEfz4b. https://t.co/yhzk2MyZE3
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Lit review of MDA5 antibody-positive clinically amyopathic dermatomyositis w/ ILD - shows limited data from 15 studies, 388 pts, 1 RCT: ? best survival with high-dose steroids + immunosuppressive (CTX or CyA/tacrolimus). Refractory dz Rx w/PLEX, Tofa, RTX https://t.co/LIl23O6x2Y https://t.co/qvISwpr7Mw
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Dr. J Merola discusses the bridges and gaps in PsO/PsA care here in the US. #RNL2022 @RheumNow https://t.co/hIdtRzeUC3
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
#ClinicalPearl? Microbiome changes if on vancomycin but not #methotrexate. ? Relevance Dunno #RNL2022 @RheumNow https://t.co/skvu2WGq8w
Janet Pope @Janetbirdope ( View Tweet )
4 years 4 months ago
Network meta-analysis reviewing PsO biologic treatments and QoL reviewed by Dr. K. Gordon at #RNL2022 @RheumNow https://t.co/BV8s1LJ7VX
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
"Going to a dermatologist is like going to a bagel shop, you're gonna get a 'smear'" - Dr. K Gordon #RNL2022 on use of topical corticosteroids as a tool that we should not forget for pts w/#psoriasis https://t.co/vCjMyKe5AE
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 4 months ago
Such a great and rewarding experience of my first visit to Texas #RNL2022 @RheumNow @UnaMakris https://t.co/fHqX292yzq
Elena MyasoedovaMD @MyasoedovaElena ( View Tweet )
4 years 4 months ago
Phases preceding RA diagnosis.
@karen_kc123 @RheumNow #RNL2022 https://t.co/KJT9ml8ZJY
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
4 years 4 months ago
Completed early RA prevention trial!
One dose of Rituximab at day zero in the PRAIRI Trial, delayed onset of RA diagnosis.
After 36 months mo difference .
@karen_kc123 @RheumNow #RNL2022 https://t.co/R3639V6b07
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
4 years 4 months ago
